CAR T at UCLA: Driving the Progress of Engineered Cell Therapy | UCLA Health HD

Join UCLA hematologist, Sarah Larson, MD, for a discussion on the recently approved CAR T cell therapy for lymphoma. She will focus on the latest research to improve the safety and efficacy of this promising therapeutic approach. Learn more: https://www.uclahealth.org/car-t-cell-therapy #UCLAMDChat